Novo Nordisk (NVO.US) Q3 2026 Earnings Call
Live time Nov 4, 2026 12:00 UTC
Novo Nordisk (NVO.US) Q3 2026 Earnings Call
Earnings Call · 1.3K views · Nov 4 12:00
诺和诺德公司 (NVO.US) 2026 年第三季度业绩电话会
Risk Disclaimer: The content on this page represents the author's personal opinions for general information purposes only and should not be used as a basis for any specific investment, business or commercial decision. It does not represent the position of Longbridge, and the platform makes no guarantees or commitments regarding the authenticity, accuracy or originality of the above content.
Novo Nordisk (NVO.US) Q3 2026 Earnings Call
Earnings Call · 1.3K views · Nov 4 12:00
诺和诺德公司 (NVO.US) 2026 年第三季度业绩电话会
Financial overview
Summary
K
Karsten Munk Knudsen
Executive VP, CFO & Member of the Management Board
M
Martin Holst Lange
EVP of R&D, Chief Scientific Officer and Member of the Management Board
J
Jamie Millar
EVP U.S. Operations
E
Emilie Konk Seil Larsen
EVP International Operations
M
Maziar Mike Doustdar
President, CEO & Member of the Management Board
M
Michael Novod
Head of Investor Relations
Announcements
Novo Nordisk AS | (6-K) Report by foreign issuer of material events
Nov 16, 2026 11:15 (ET)
Novo Nordisk AS | (6-K) Report by foreign issuer of material events
Nov 9, 2026 08:09 (ET)
Risk Disclaimer: The content on this page represents the author's personal opinions for general information purposes only and should not be used as a basis for any specific investment, business or commercial decision. It does not represent the position of Longbridge, and the platform makes no guarantees or commitments regarding the authenticity, accuracy or originality of the above content.
